70 related articles for article (PubMed ID: 1683218)
1. [Vasodilator drugs that act by stimulating guanylate cyclase in vascular smooth muscle].
Castillo C; Hong E
Arch Inst Cardiol Mex; 1991; 61(4):375-84. PubMed ID: 1683218
[TBL] [Abstract][Full Text] [Related]
2. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
Murad F; Waldman S; Molina C; Bennett B; Leitman D
Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
[TBL] [Abstract][Full Text] [Related]
3. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
Papapetropoulos A; Cziraki A; Rubin JW; Stone CD; Catravas JD
J Cell Physiol; 1996 May; 167(2):213-21. PubMed ID: 8613461
[TBL] [Abstract][Full Text] [Related]
4. Regulation of contractile activity in vascular smooth muscle by protein kinases.
Silver PJ
Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
[TBL] [Abstract][Full Text] [Related]
5. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system.
Waldman SA; Murad F
J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S115-8. PubMed ID: 2469867
[TBL] [Abstract][Full Text] [Related]
6. Differential alterations in responsiveness in particulate and soluble guanylate cyclases in pregnant guinea pig myometrium.
Buhimschi IA; San Martin-Clark O; Aguan K; Thompson LP; Weiner CP
Am J Obstet Gynecol; 2000 Dec; 183(6):1512-9. PubMed ID: 11120520
[TBL] [Abstract][Full Text] [Related]
7. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.
Rapoport RM; Murad F
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):281-96. PubMed ID: 6147363
[TBL] [Abstract][Full Text] [Related]
9. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
10. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
11. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
[TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms of action of atrial natriuretic factor.
Gerzer R; Heim JM; Schütte B; Weil J
Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
[TBL] [Abstract][Full Text] [Related]
15. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
16. Role of cyclic-GMP in relaxations of vascular smooth muscle.
Murad F; Rapoport RM; Fiscus R
J Cardiovasc Pharmacol; 1985; 7 Suppl 3():S111-8. PubMed ID: 2409383
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
18. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
19. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
Priviero FB; Teixeira CE; Toque HA; Claudino MA; Webb RC; De Nucci G; Zanesco A; Antunes E
Clin Exp Pharmacol Physiol; 2006; 33(5-6):448-55. PubMed ID: 16700877
[TBL] [Abstract][Full Text] [Related]
20. Effects of nitrovasodilators, endothelium-dependent vasodilators, and atrial peptides on cGMP.
Murad F; Leitman D; Waldman S; Chang CH; Hirata M; Kohse K
Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 2():1005-9. PubMed ID: 2908195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
